|
|
|
| Effect of Tongxinluo Capsules on cerebral infarction patients with the syndrome of qi deficiency and blood stasis |
| DONG Yanhua ZHU Lianying#br# |
| Department of Internal Medicine, the People’s Hospital of Huaiyin, Shandong Province, Jinan 250002, China |
|
|
|
Abstract Objective To explore the clinical effect of Tongxinluo Capsules on cerebral infarction patients with the syndrome of qi deficiency and blood stasis. Methods A total of 80 cerebral infarction patients with the syndrome of qi deficiency and blood stasis from June 2019 to May 2020 in the People’s Hospital of Huaiyin, Shandong Province were selected as the research objects, and they were randomly divided into control group (40 cases) and research group (40 cases). The control group received conventional Western medicine treatment, and the research group received Tongxinluo Capsules on the basis of the control group. After 28 d of treatment, limb motor function, walking ability, nerve damage situation, and self-care ability of two groups were evaluated. Results There were two cases of detachment, all male patients in the study group. After treatment, Fugl-Meyer motor scale scores of upper and lower limbs in the two groups were higher than those before treatment, and those in the study group were higher than those in the control group (P ＜ 0.05). After treatment, the scores of walking ability in the two groups were lower than those before treatment, and that in the study group was lower than that in the control group (P ＜ 0.05). After treatment, the scores of National Institutes of health stroke scale in the two groups were lower than those before treatment, and that in the study group was lower than that in the control group (P ＜ 0.05). After treatment, the scores of daily living activities in the two groups were higher than those before treatment, and that in the study group was higher than that in the control group (P ＜ 0.05). Conclusion Tongxinluo Capsules can improve the limb motor function and self-care ability of cerebral infarction patients with the syndrome of qi deficiency and blood stasis, promote the recovery of patients’ cerebral nerve function, help to improve the clinical treatment effect, and is worthy of clinical application.
|
|
|
|
|
|
[1] 李潘孝，乐道平，郑志洲，等.通心络胶囊联合氯吡格雷对急性脑梗死患者康复阶段认知功能及生活质量影响[J].创伤与急危重病医学，2021，9（5）：345-348.
[2] 张俊红.通心络胶囊联合阿加曲班治疗轻中度急性脑梗死的疗效观察[J].现代药物与临床，2020，35（3）：465-468.
[3] 陈宜德，江凌翔，卓徐鹏，等.通心络胶囊联合依达拉奉治疗老年急性脑梗死的疗效及对神经功能和血脂的影响[J].中国老年学杂志，2021，41（5）：930-933.
[4] 周正芳，王洪建，孙峰.通心络与脑络欣通在脑梗死恢复期气虚血瘀证治疗中的疗效比较[J].贵州医药，2019，43（7）：1133-1134.
[5] 杨旸，樊萍，潘琳娜，等.通心络胶囊在气虚痰瘀阻络型中风早期应用研究[J].陕西中医，2018，39（6）：706-709.
[6] 中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志，2018，51（9）：666-682.
[7] 中华中医药学.中医内科常见病诊疗指南·西医疾病部分[S].北京：中国中医药出版社，2008：258-264.
[8] 中华医学会神经病学分会神经康复学组，中华医学会神经病学分会脑血管组，卫生部脑中筛查与防治工程委员会办公室.中国脑卒中康复治疗指南（2011完全版）[J].中国康复理论与实践，2012，18（4）：1-18.
[9] 南登昆，郭正成.康复医学临床指南[M].北京：科学出版社，1999：35-39.
[10] 中华神经科学会.脑卒中患者临床神经功能缺损程度评分标准（1995）[J].中华神经科杂志，1996，29（6）：381-383.
[11] 张磊，刘建民.美国国立卫生研究院卒中量表[J].中华神经外科杂志，2014，30（1）：79.
[12] 王瑞华.日常生活活动能力（ADL）的测定[J].中级医刊，1994（4）：7.
[13] 朱勇刚.补阳还五汤联合丁苯酞治疗脑梗死气虚血瘀型临床观察[J].实用中医药杂志，2021，37（7）：1148-1150.
[14] 李洁，郝宗霞，郑萍红，等.血府逐瘀汤加减治疗气虚血瘀型脑梗死临床研究[J].新中医，2021，53（17）：42-46.
[15] 强茗，胡元娟.益气通络汤对气虚血瘀型脑梗死患者功能恢复的作用研究[J].实用医院临床杂志，2021，18（4）：12-15.
[16] 俞文菁，杨雄杰.卒中后认知功能障碍与中医证型的相关性研究[J].湖南中医杂志，2021，37（5）：1-4.
[17] 游承锟.穴位埋线合补阳还五汤治疗气虚血瘀型脑梗死的临床观察[D].南昌：江西中医药大学，2021.
[18] 窦维华，陈燕，吴鹏，等.梗塞通2号方与补阳还五汤治疗气虚血瘀型脑梗死的疗效比较研究[J].实用心脑肺血管病杂志，2021，29（2）：93-97，107.
[19] 肖海凌，郭珍立.益气活血法治疗气虚血瘀型脑梗死合并急性肾损伤疗效观察及对血清胱抑素C水平的影响[J].山西中医，2021，37（1）：18-20.
[20] 王缘，徐浩刚.涤痰化瘀汤对风痰入络证脑梗死急性期患者血清NO、ET水平的影响[J].中国医药导报，2022， 19（6）：127-130.
[21] 万军锋，徐长青，李蒲城.通心络胶囊联合丁苯酞治疗急性脑梗死的效果[J].临床医学研究与实践，2020，5（21）：68-70.
[22] 樊萍，潘琳娜，杨旸.通心络胶囊在不同中医证候脑梗死二级预防中的疗效比较研究[J].江西中医药大学学报，2018，30（2）：44-46.
[23] 栗艳婵.急性脑梗死采用通心络胶囊治疗的药理和临床效果分析[J].系统医学，2019，4（9）：151-153.
[24] 金亚娟，曹旸，霍康.通心络胶囊联合西药治疗急性脑梗死39例[J].西部中医药，2018，31（12）：74-76.
[25] 吕昀，李学玲，李文战，等.通心络对脑梗死大鼠的神经保护作用[J].中国实用神经疾病杂志，2009，12（15）：37-38.
[26] 欧阳征，唐红宇，王爱民，等.通心络胶囊治疗早期缺血性脑卒中的临床研究[J].现代医药卫生，2017，33（11）：1604-1607. |
|
|
|
